<http://mountaingroup.wpengine.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-bene-ts-patients-small-cell-lung-cancer/#webpage>
<http://schema.org/inLanguage>
"en-US"
<https://mtngp.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-bene-ts-patients-small-cell-lung-cancer/>